1400W
Based on 29 publication(s) in Google Scholar
1400W is a slow, tight binding, and highly selective inducible nitric-oxide synthase (iNOS) inhibitor, with a Kd value ≤ 7 nM. 1400W inhibits iNOS induction in microglial cells, and reduces generation of NO, thereby mitigating oxidative stress and neuronal cell apoptosis in the rat cerebral cortex, and improving the spatial memory dysfunction caused by acute hypobaric hypoxia-reoxygenation.
For research use only. We do not sell to patients.
- Purity: 98.49%
- CAS No.: 180001-34-7
- Formula: C10H15N3
- Molecular Weight:177.25
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Publications Citing Use of MedChemExpress (MCE) 1400W
More- Signal Transduct Target Ther. 2025 Jul 3;10(1):209. [Abstract]
- Cell Metab. 2025 Jan 7;37(1):291-304.e9. [Abstract]
- Mol Cell. 2020 Jan 2;77(1):95-107.e5. [Abstract]
- ACS Nano. 2025 Mar 11;19(9):9390-9411. [Abstract]
- Nat Commun. 2025 Dec 3;17(1):255. [Abstract]
- Redox Biol. 2023 Nov:67:102905. [Abstract]
- Hum Reprod Open. 2026 Feb 17;2026(2):hoag013. [Abstract]
- ISME J. 2024 Jan 8;18(1):wrae014. [Abstract]
- Int J Biol Sci. 2020 Mar 5;16(9):1563-1574. [Abstract]
- Cancer Immunol Res. 2026 May 4;14(5):875-891. [Abstract]
- Sci Total Environ. 2020 Jan 1;698:134294. [Abstract]
- Mucosal Immunol. 2024 Apr;17(2):288-302. [Abstract]
- J Transl Med. 2023 Nov 25;21(1):852. [Abstract]
- Biomed Pharmacother. 2022 Sep;153:113532. [Abstract]
- Biomed Pharmacother. 2022 Jul;151:113098. [Abstract]
- Aging Cell. 2025 Feb 6:e14502. [Abstract]
- Cell Rep. 2022 Feb 15;38(7):110391. [Abstract]
- Int Immunopharmacol. 2026 Mar 1:172:116240. [Abstract]
- Neuropharmacology. 2025 Aug 29:280:110662. [Abstract]
- J Physiol. 2024 Jul 26. [Abstract]
- Skelet Muscle. 2022 Jul 29;12(1):19. [Abstract]
- iScience. 2023 Jul 10;26(8):107353. [Abstract]
- Mol Cell Biochem. 2025 Aug 3. [Abstract]
- Microvasc Res. 2023 Mar:146:104468. [Abstract]
- Biochem Biophys Res Commun. 2025 Jan 19:749:151345. [Abstract]
- Int J Ophthalmol. 2022 Jul 18;15(7):1053-1061. [Abstract]
- bioRxiv. 2026 Jun 4.
- bioRxiv. 2025 Feb 17.
- University of Jena. 2023 Dec.
-
Cell Proliferation/Viability Assay
-
WB
-
Flow Cytometry
-
WB
-
WB
Biological Activity
Ki: 2 µM (nNOS), 50 µM (eNOS)[1]
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| MDA-MB-231 | EC50 |
>100 μM
Compound: 1400W
|
Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability measured after 5 days by PrestoBlue reagent based assay
Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability measured after 5 days by PrestoBlue reagent based assay
|
[PMID: 36641860] |
| N9 | IC50 |
2.2 μM
Compound: N-(3-aminomethyl)benzylacetamidine
|
Inhibitory effect of compound on the accumulation of NO2 in the culture media of N9 cells in response to LPS/IFN-gamma
Inhibitory effect of compound on the accumulation of NO2 in the culture media of N9 cells in response to LPS/IFN-gamma
|
[PMID: 15013012] |
| N9 | IC50 |
3.6 μM
Compound: 1400W
|
Antiinflammatory activity in LPS/IFN-gamma-stimulated mouse N9 cells assessed as inhibition of nitric oxide production pretreated 1 hr before LPS/IFNgamma challenge
Antiinflammatory activity in LPS/IFN-gamma-stimulated mouse N9 cells assessed as inhibition of nitric oxide production pretreated 1 hr before LPS/IFNgamma challenge
|
[PMID: 12662101] |
| N9 | IC50 |
6.3 μM
Compound: 1400W
|
Antiinflammatory activity against mouse N9 cells assessed as inhibition of LPS/IFN-gamma-induced nitrite accumulation after 24 hrs
Antiinflammatory activity against mouse N9 cells assessed as inhibition of LPS/IFN-gamma-induced nitrite accumulation after 24 hrs
|
[PMID: 15568764] |
| RAW | IC50 |
5.2 μM
Compound: N-(3-aminomethyl)benzylacetamidine
|
Inhibition of 1ug/ml LPS-stimulated nitirc oxide accumulation in RAW 264 cells after 24 hrs
Inhibition of 1ug/ml LPS-stimulated nitirc oxide accumulation in RAW 264 cells after 24 hrs
|
[PMID: 17320246] |
| RAW | IC50 |
6.1 μM
Compound: N-(3-aminomethyl)benzylacetamidine
|
Inhibitory effect of compound on the accumulation of NO2 in the culture media of RAW 264.7 cells in response to LPS
Inhibitory effect of compound on the accumulation of NO2 in the culture media of RAW 264.7 cells in response to LPS
|
[PMID: 15013012] |
| RAW264.7 | IC50 |
>10 μM
Compound: 1400W
|
Antiinflammatory activity against LPS-stimulated mouse RAW264.7 cells assessed as PGE2 accumulation after 20 hrs by RIA
Antiinflammatory activity against LPS-stimulated mouse RAW264.7 cells assessed as PGE2 accumulation after 20 hrs by RIA
|
[PMID: 11678654] |
| RAW264.7 | IC50 |
0.2 μM
Compound: 1400W
|
Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs by Griess assay
Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs by Griess assay
|
[PMID: 23232148] |
| RAW264.7 | IC50 |
0.3 μM
Compound: 1400W
|
Antiinflammatory activity against LPS-stimulated mouse RAW264.7 cells assessed as nitrite accumulation after 20 hrs by fluorimetry
Antiinflammatory activity against LPS-stimulated mouse RAW264.7 cells assessed as nitrite accumulation after 20 hrs by fluorimetry
|
[PMID: 11678654] |
| RAW264.7 | IC50 |
1.5 μM
Compound: 1400W
|
Inhibition of LPS-induced nitric oxide generation in mouse RAW264.7 cells pretreated 1 hr before LPS challenge by Griess method
Inhibition of LPS-induced nitric oxide generation in mouse RAW264.7 cells pretreated 1 hr before LPS challenge by Griess method
|
[PMID: 19278854] |
| RAW264.7 | IC50 |
2.3 μM
Compound: 1400W
|
Antiinflammatory activity in LPS-stimulated mouse RAW264.7 cells assessed as inhibition of nitric oxide production pretreated 1 hr before LPS challenge
Antiinflammatory activity in LPS-stimulated mouse RAW264.7 cells assessed as inhibition of nitric oxide production pretreated 1 hr before LPS challenge
|
[PMID: 12662101] |
| RAW264.7 | IC50 |
2.7 μM
Compound: 1400W
|
Inhibition of LPS-induced nitric oxide accumulation in mouse RAW264.7 cells
Inhibition of LPS-induced nitric oxide accumulation in mouse RAW264.7 cells
|
[PMID: 19699097] |
| RAW264.7 | IC50 |
2.9 μM
Compound: 1400W
|
Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced nitrite accumulation after 24 hrs
Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced nitrite accumulation after 24 hrs
|
[PMID: 15568764] |
| RAW264.7 | IC50 |
3.1 μM
Compound: 1400W
|
Antiinflammatory activity in LPS-stimulated mouse RAW264.7 cells assessed as effect on NO production pretreated 1 hr before LPS challenge measured after 24 hrs
Antiinflammatory activity in LPS-stimulated mouse RAW264.7 cells assessed as effect on NO production pretreated 1 hr before LPS challenge measured after 24 hrs
|
[PMID: 11908984] |
| RAW264.7 | IC50 |
3.78 μM
Compound: 1400W
|
Inhibition of LPS-induced nitric oxide production in mouse RAW264.7 cells
Inhibition of LPS-induced nitric oxide production in mouse RAW264.7 cells
|
[PMID: 17988874] |
| RAW264.7 | IC50 |
47.47 μM
Compound: 1400W
|
Cytotoxicity against mouse RAW264.7 cells assessed as cell viability after 24 hrs by MTS assay
Cytotoxicity against mouse RAW264.7 cells assessed as cell viability after 24 hrs by MTS assay
|
[PMID: 23232148] |
| THP-1 | IC50 |
0.33 μM
Compound: 1, W1400
|
Inhibition of iNOS in LPS treated human THP1 cell homogenate assessed as conversion of L-[2,3-3H]arginine to L-[2,3-3H]citrulline pre-incubated 1 hr before LPS challenge by whole cell assay
Inhibition of iNOS in LPS treated human THP1 cell homogenate assessed as conversion of L-[2,3-3H]arginine to L-[2,3-3H]citrulline pre-incubated 1 hr before LPS challenge by whole cell assay
|
[PMID: 19203270] |
| THP-1 | IC50 |
1100 μM
Compound: 1, W1400
|
Inhibition of eNOS in LPS treated human THP1 cell homogenate assessed as conversion of L-[2,3-3H]arginine to L-[2,3-3H]citrulline pre-incubated 1 hr before LPS challenge by whole cell assay
Inhibition of eNOS in LPS treated human THP1 cell homogenate assessed as conversion of L-[2,3-3H]arginine to L-[2,3-3H]citrulline pre-incubated 1 hr before LPS challenge by whole cell assay
|
[PMID: 19203270] |
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 180001-34-7
-
Appearance Solid
-
Molecular Weight 177.25
-
Formula C10H15N3
-
Color White to off-white
-
SMILES
CC(NCC1=CC=CC(CN)=C1)=N
-
Synonyms
W1400
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Publications (29)
-
Journal Impact Factor
-
Most Recent
-
Signal Transduct Target Ther
Oleic acid restores the impaired antitumor immunity of γδ-T cells induced by palmitic acid. [Abstract]2025 Jul 3;10(1):209. PMID: 40603316
1400W purchased from MedChemExpress. Usage Cited in: Signal Transduct Target Ther. 2025 Jul 3;10(1):209. [Abstract]
1400W dihydrochloride inhibited PA-induced LDH release in Vγ9Vδ2-T cells.
1400W purchased from MedChemExpress. Usage Cited in: Signal Transduct Target Ther. 2025 Jul 3;10(1):209. [Abstract]
1400W dihydrochloride treatment effectively suppressed the induction of GSDMD cleavage and caspase 1 activation of Vγ9Vδ2-T cells following rhIFNγ stimulation under BSA or OA conditions.
-
Cell Metab
Lighting up arginine metabolism reveals its functional diversity in physiology and pathology. [Abstract]2025 Jan 7;37(1):291-304.e9. PMID: 39413790
1400W purchased from MedChemExpress. Usage Cited in: Cell Metab. 2025 Jan 7;37(1):291-304.e9. [Abstract]
Effects of NOS inhibitors on phagocytosis efficiency in M0 and M1 BMDMs. The results showed that treatment with the NOS inhibitor 1400W dihydrochloride suppressed the phagocytic efficiency of activated M1 BMDMs, implying that NOS‑mediated arginine metabolism was crucial for macrophage phagocytosis.
-
Mol Cell
PTPS Facilitates Compartmentalized LTBP1 S-Nitrosylation and Promotes Tumor Growth under Hypoxia. [Abstract]2020 Jan 2;77(1):95-107.e5. PMID: 31628042
1400W purchased from MedChemExpress. Usage Cited in: Mol Cell. 2020 Jan 2;77(1):95-107.e5. [Abstract]
HT29 cells with depleted PTPS and reconstituted expression of rPTPS R25Q were cultured for 12 h under hypoxia and were treated with the indicated concentration of exogenous BH4 in the presence or absence of 1400W Dihydrochloride (100 μM). The S-nitrosylation detection assay was performed. Addition of a high dosage of exogenous BH4 led to an increased LTBP1 S-nitrosylation under hypoxia in HT29 cells with expression of PTPS R25Q. The effects of exogenous BH4 found here were abolished when cells were treated with the iNOS inhibitor 1400W Dihydrochloride.
1400W purchased from MedChemExpress. Usage Cited in: Mol Cell. 2020 Jan 2;77(1):95-107.e5. [Abstract]
HT29 cells with depleted PTPS and reconstituted expression of rPTPS R25Q were cultured for 12 h under hypoxia and were added with indicated concentrations of exogenous BH4 in the presence or absence of 1400W Dihydrochloride (100 mM). Cells were treated with cycloheximide (CHX; 30 mg/mL) for the indicated length of time at 6 h under hypoxia treatment. Immunoblotting and relative intensities of LTBP1 to beta-actin were analyzed. Addition of a high dosage of exogenous BH4 led to decreased LTBP1 stability and increased LTBP1 ubiquitination. The effects of exogenous BH4 were abolished when cells were treated with the iNOS inhibitor 1400W Dihydrochloride.
-
ACS Nano
Microneedles Loaded with Nitric-Oxide Driven Nanomotors Improve Force-Induced Efferocytosis Impairment and Sterile Inflammation by Revitalizing Macrophage Energy Metabolism. [Abstract]2025 Mar 11;19(9):9390-9411. PMID: 40025734 -
Nat Commun
USP16 S-nitrosylation aggravates coronary microembolization-induced myocardial injury via repressing KDM1A-mediated glutathione homeostasis. [Abstract]2025 Dec 3;17(1):255. PMID: 41339351 -
Redox Biol
VEO-IBD NOX1 variant highlights a structural region essential for NOX/DUOX catalytic activity. [Abstract]2023 Nov:67:102905. PMID: 37820403 -
Hum Reprod Open
Impaired PIEZO1 function drives uterine hypercontractility in adenomyosis-associated dysmenorrhea. [Abstract]2026 Feb 17;2026(2):hoag013. PMID: 41836349 -
ISME J
Protozoan predation enhances stress resistance and antibiotic tolerance in Burkholderia cenocepacia by triggering the SOS response. [Abstract]2024 Jan 8;18(1):wrae014. PMID: 38366016 -
Int J Biol Sci
Downregulation of Nitric Oxide Collaborated with Radiotherapy to Promote Anti-Tumor Immune Response via Inducing CD8+ T Cell Infiltration. [Abstract]2020 Mar 5;16(9):1563-1574. PMID: 32226302 -
Cancer Immunol Res
CLK1 Promotes Myeloid-Derived Suppressor Cell Trafficking and Reprograms the Tumor Microenvironment by Activating Hippo/YAP Signaling in Colorectal Cancer. [Abstract]2026 May 4;14(5):875-891. PMID: 41686262 -
Sci Total Environ
Manganese induces autophagy dysregulation: The role of S-nitrosylation in regulating autophagy related proteins in vivo and in vitro. [Abstract]2020 Jan 1;698:134294. PMID: 31783459 -
Mucosal Immunol
Deficiency of immunoglobulin IgSF6 enhances antibacterial effects by promoting ER stress and the inflammatory response in intestinal macrophages. [Abstract]2024 Apr;17(2):288-302. PMID: 38387824 -
J Transl Med
Paneth cell-derived iNOS is required to maintain homeostasis in the intestinal stem cell niche. [Abstract]2023 Nov 25;21(1):852. PMID: 38007452 -
Biomed Pharmacother
Oridonin attenuates lung inflammation and fibrosis in silicosis via covalent targeting iNOS. [Abstract]2022 Sep;153:113532. PMID: 36076611 -
Biomed Pharmacother
Dendrobium officinale polysaccharides attenuate uropathogenic Escherichia coli (UPEC)-induced pyroptosis in macrophage cells. [Abstract]2022 Jul;151:113098. PMID: 35594714 -
Aging Cell
Aging-Associated Liver Sinusoidal Endothelial Cells Dysfunction Aggravates the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease. [Abstract]2025 Feb 6:e14502. PMID: 39912563 -
Cell Rep
2022 Feb 15;38(7):110391. PMID: 35172156 -
Int Immunopharmacol
A novel triazole derivative ameliorates ethanol-induced gastric ulcer via a NOS2-centered inhibition of the AGE-RAGE pathway. [Abstract]2026 Mar 1:172:116240. PMID: 41576570 -
Neuropharmacology
Microglial-derived nitric oxide regulates amygdala synaptic plasticity to drive chronic pain and depression induced by lumbar disc herniation. [Abstract]2025 Aug 29:280:110662. PMID: 40887007 -
J Physiol
The protective effect of 1400W against ischaemia and reperfusion injury is countered by transient medullary kidney endothelial dysregulation. [Abstract]2024 Jul 26. PMID: 39057844 -
Skelet Muscle
Oxidative stress-induced premature senescence and aggravated denervated skeletal muscular atrophy by regulating progerin-p53 interaction. [Abstract]2022 Jul 29;12(1):19. PMID: 35906707 -
iScience
2023 Jul 10;26(8):107353. PMID: 37529099 -
Mol Cell Biochem
Nitric oxide induces apoptosis of human primary melanocytes by regulating calcium homeostasis via VDAC1. [Abstract]2025 Aug 3. PMID: 40753527 -
Microvasc Res
Hypoglycaemia aggravates impaired endothelial-dependent vasodilation in diabetes by suppressing endothelial nitric oxide synthase activity and stimulating inducible nitric oxide synthase expression. [Abstract]2023 Mar:146:104468. PMID: 36513147 -
Biochem Biophys Res Commun
A novel genetically encoded indicator for deciphering cytosolic and mitochondrial nitric oxide in live cells. [Abstract]2025 Jan 19:749:151345. PMID: 39862720 -
Int J Ophthalmol
Dynamic changes of inducible nitric oxide synthase expression in rat's retina and its role on blood-retinal barrier injury after acute high intraocular pressure. [Abstract]2022 Jul 18;15(7):1053-1061. PMID: 35919326 -
-
-
Solvent & Solubility
DMSO : 100 mg/mL (564.17 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 5 mg/mL (28.21 mM); Clear solution
This protocol yields a clear solution of ≥ 5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (50.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 5 mg/mL (28.21 mM); Clear solution
This protocol yields a clear solution of ≥ 5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (50.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation
-
Data Sheet (271 KB)
-
SDS (392 KB)
- English - EN (392 KB)
- Français - FR (392 KB)
- Deutsch - DE (392 KB)
- Norwegian - NO (392 KB)
- Español - ES (392 KB)
- Swedish - SV (392 KB)
- Italian - IT (392 KB)
- Korean - KR (392 KB)
- Portuguese - PT (392 KB)
-
Handling Instructions (2659 KB)
References
[1]. Garvey EP, et al. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J Biol Chem. 1997 Feb 21;272(8):4959-63. [Content Brief]
[2]. Shi Q, et al. 1400W ameliorates acute hypobaric hypoxia/reoxygenation-induced cognitive deficits by suppressing the induction of inducible nitric oxide synthase in rat cerebral cortex microglia. Behav Brain Res. 2017 Feb 15;319:188-199. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 5.6417 mL | 28.2087 mL | 56.4175 mL | 141.0437 mL |
| 5 mM | 1.1283 mL | 5.6417 mL | 11.2835 mL | 28.2087 mL | |
| 10 mM | 0.5642 mL | 2.8209 mL | 5.6417 mL | 14.1044 mL | |
| 15 mM | 0.3761 mL | 1.8806 mL | 3.7612 mL | 9.4029 mL | |
| 20 mM | 0.2821 mL | 1.4104 mL | 2.8209 mL | 7.0522 mL | |
| 25 mM | 0.2257 mL | 1.1283 mL | 2.2567 mL | 5.6417 mL | |
| 30 mM | 0.1881 mL | 0.9403 mL | 1.8806 mL | 4.7015 mL | |
| 40 mM | 0.1410 mL | 0.7052 mL | 1.4104 mL | 3.5261 mL | |
| 50 mM | 0.1128 mL | 0.5642 mL | 1.1283 mL | 2.8209 mL | |
| 60 mM | 0.0940 mL | 0.4701 mL | 0.9403 mL | 2.3507 mL | |
| 80 mM | 0.0705 mL | 0.3526 mL | 0.7052 mL | 1.7630 mL | |
| 100 mM | 0.0564 mL | 0.2821 mL | 0.5642 mL | 1.4104 mL |